David Myung is an Associate Professor in the Department of Ophthalmology at Stanford University. He specializes in cataract and corneal surgery as well as the management of external eye diseases. Dr. Myung serves as the Director of the Ophthalmic Innovation Program and has developed a translational research laboratory funded by the NIH and DoD. His research interests include ophthalmic regenerative medicine, tissue engineering, and drug delivery systems. He is particularly focused on using bio-orthogonal chemistries for the localized delivery of growth factors and stem cells to enhance healing in ocular tissues. Dr. Myung also leads the STATUS Program, aimed at enabling telemedicine solutions to improve eye care access globally, especially in resource-limited settings. His dedication to integrating AI with telemedicine reflects his commitment to innovating healthcare delivery. He has contributed significantly to various awards such as the High Impact Technology Award from Stanford and the Harrington Scholar-Innovator Award. His recent projects involve developing new biopolymeric tissue scaffolds and 3D bioprintable inks for tissue engineering applications.
Stanford University • Palo Alto, CA
Serves as an Associate Professor in the Ophthalmology department with a focus on translational research and innovative technologies in eye care.
Stanford Teleophthalmology Autonomous Testing Universal Screening (STATUS) Program • Palo Alto, CA
Leads a program aiming to enhance digital health technologies in eye care.
Byers Family Ophthalmic Innovation Fellowship Program • Palo Alto, CA
Directs a fellowship program dedicated to innovation in ophthalmic education.